Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Healthy People 2020 Heart Disease and Stroke Health Survey CDC, OS NHLBI, NINDS The purpose of the collaborative activity is to support the development by the National Health Interview Survey (NHIS) of measures that can be used to assess progress toward achieving Healthy People 2020 Heart Disease, Blood Pressure, and Cholesterol Objectives to improve cardiovascular health and quality of life through prevention, detection, and treatment of risk factors for heart attack and stroke; promote early identification and treatment of heart attacks and strokes; and prevent of repeat cardiovascular events. The NIH, CDC, and the National Center for Health Statistics collaborate on this activity.
Healthy People 2020 Progress Review on Substance Abuse and Mental Disorders Meeting/ Workshop OS, SAMHSA NIMH, NIDA On February 26, 2014, NIMH hosted a Healthy People 2020 Progress Review Webinar on “Substance Use and Mental Disorders: Early Detection, Prevention, and Treatment.” NIMH Deputy Director Philip Wang, M.D., Dr.P.H. presented on the state of science for mental health and mental disorders, with a focus on NIMH efforts related to suicide prevention and early detection of serious mental illness, including schizophrenia and related disorders. In addition, the webinar featured Howard Koh, M.D., M.P.H., Assistant Secretary for Health, DHHS, and presenters from other federal agencies including the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
Healthy People 2020-Dementias, Including Alzheimer''s Disease Committee, Work group, Advisory group, or Task Force CDC NIA, NIMH, NINDS This Healthy People 2020 topic will focus on increasing the awareness of the diagnosis of Alzheimer’s disease, and reducing the proportion of preventable hospitalizations in persons with diagnosed Alzheimer’s disease and other dementias. The goal is to reduce the morbidity and costs associated with, and maintain or enhance the quality of life for, persons with dementia, including Alzheimer’s disease.
Healthy Vision Month Public Education Campaign CDC NEI Each May, the NEI sponsors Healthy Vision Month (HVM) which is a national observance designed to elevate eye health as a priority for Americans. NIH worked with CDC for the 2014 observance to disseminate disease information for CDC''s Vision Initiative website and provided online banners and buttons linking to the HVM site and to the NEI for additional information.
Hematopoietic Stem Cell Transplantation Interagency Working Group Committee, Work group, Advisory group, or Task Force FDA, HRSA NCI, CC, NHLBI, NIAID, NIDDK This working group reviews matters associated with hematopoietic stem cell transplantation.
Hemophilia/Hep C Project Committee, Work group, Advisory group, or Task Force CDC NHLBI The Working Group supports the design and conduct of the Hemophilia/Hep C Project.
Hepatitis B Research Network Research Initiative CDC NIDDK The Hepatitis B Research Network (HBRN) was established in 2008 to advance understanding of disease processes and natural history of chronic hepatitis B, as well as to develop effective approaches to treatment with currently available therapies. The Network brings together clinical centers from throughout the U.S. and Canada. This multi-center Network is enrolling patients in multiple clinical trials in both adults and children with hepatitis B.
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG) Research Initiative AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA NIDA, NIAID, NIDDK, NIMHD HHS agencies review the Institute of Medicine (IOM) recommendations and develop a comprehensive strategic viral hepatitis action plan that would: address IOM recommendations for viral hepatitis prevention, care, and treatment; set forth actions to improve viral hepatitis prevention and ensure that infected persons are identified and provided care and treatment; and improve coordination of all activities related to viral hepatitis across HHS and promote collaborations with other government agencies and nongovernmental organizations.
HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA) Committee, Work group, Advisory group, or Task Force CDC, CMS, FDA, HRSA, OS NHLBI, CC This federal advisory committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood (and tissue) safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical, and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood (and tissue) safety and availability (and infectious disease concerns for organ transplantation). The ACBTSA is a Federal Advisory Committee (i.e., a FACA) seated with industry representatives, physicians/scientists, consumer advocates, and federal ex-officio members from the HHS Agencies, the Department of Defense, and the Department of Veteran''s Affairs.
HHS Behavioral Health Coordinating Committee Other ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/OCPL The HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. Co-chaired by the Assistant Secretary for Health, and the Administrator of the Substance Abuse and Mental Health Services Administration, and is made up of various and changing subcommittees. The committee is charged with coordinating behavioral health activities across HHS, and has five subcommittees addressing early intervention; prescription drug abuse; teenage drinking; integrating behavioral health care with primary care; and, behavioral health communications. The subcommittees develop projects with clear goals, provide guidance to achieve steady progress and measurable outcomes, and develop key policy messages. The projects and activities build upon existing activities in the proposed areas and are consistent with other important HHS and Federal strategies and initiatives, such as Healthy People, the U.S. Preventive Task Force, and the National Drug Control Strategy.